N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction. N-3 PUFA supplementation in acute myocardial infarction

Clinical Nutrition

Volumn 30, Issue 1, 2011, Pages 79-85

  Haberka, Maciej ^a   Mizia Stec, Katarzyna ^a   Mizia, Magdalena ^a   Janowska, Joanna ^a   Gieszczyk, Klaudia ^a   Chmiel, Artur ^a   Zahorska Markiewicz, Barbara ^a   Gasior, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acute myocardial infarction; Asymmetric dimethylarginine; Flow mediated dilatation; Polyunsaturated fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OMEGA 3 FATTY ACID;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DRUG RESPONSE; ENDOTHELIUM; FEMALE; FLOW MEDIATED DILATATION; HEART INFARCTION; HUMAN; MALE; NITROGLYCERIN MEDIATED DILATATION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; ULTRASOUND;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARGININE; BLOOD FLOW VELOCITY; DIETARY SUPPLEMENTS; DILATATION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79451469852     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.07.011     Document Type: Article

References (46)

1. Psota T.l., Gebauer S.K., Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 2006, 98(4A):3i-18i.
2. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology. Eur Heart J 2008, 29:2909-2945.
3. Zipes D.P., Camm A.J., Borggrefe M., Chaitman B., Gregoratos G., Moss A.J., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. a report of the American college of cardiology/American heart association task force and the european society of cardiology committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European heart rhythm association and the heart rhythm society. Eur Heart J 2006, 27(17):2099-2140.
4. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl. 2):E1-E40.
5. Kris-Etherton P.M., Harris W.S., Appel L.J. AHA scientific statement: fish consumption, fish oil, Omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
6. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105(16):1897-1903.
7. Hoy S.M., Keating G.M. Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia. Drugs 2009, 69(8):1077-1105.
8. Karatzis E.N., Ikonomidis I., Vamvakou G.D., Papaioannou T.G., Protogerou A.D., Andreadou I., et al. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 2006, 98:1424-1428.
9. Fichtlscherer S., Breuer S., Zeiher A. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes. further evidence for the existence of the ″ vulnerable″ patient. Circulation 2004, 110:1926-1932.
10. Eid H., Arnesen H., Hjerkinn E.M., Lyberg T., Ellingsen I., Seljeflot I. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. Nutr Metab (Lond) 2006, 3:4.
11. Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. Nutrition 2004, 134(7):1806-1811.
12. He K., Liu K., Daviglus M.L., Jenny N.S., Mayer-Davis E., Jiang R., et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the multi-ethnic study of atherosclerosis [MESA]). Am J Cardiol 2009, 103(9):1238-1243.
13. Matsumoto T., Nakayama N., Ishida K., Kobayashi T., Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 2009, 329(1):324-334.
14. Anderson T., Uehata A., Gerhard M., Meredith I., Knab S., Delagrange D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
15. Keogh J.B., Grieger J.A., Noakes M., Clifton P.M. Flow-mediated dilatation is Impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 2005, 25:1274-1279.
16. Vallance P., Chan N. Endothelial function and nitric oxide: clinical relevance. Heart 2001, 85:342-350.
17. Meinitzer A., Seelhorst U., Wellnitz B., Halwachs-Baumann G., Boehm B.O., Winkelmann B.R., et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the ludwigshafen risk and cardiovascular health study). Clin Chem 2007, 53(2):273-283.
18. Korandji C., Zeller M., Guilland J.C., Vergely C., Sicard P., Duvillard L., et al. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction. Clin Biochem 2007, 40(1-2):66-72.
19. Böger R.H., Sullivan L.M., Schwedhelm E., Wang T.J., Maas R., Benjamin E.J., et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009, 119(12):1592-1600.
20. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilatation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002, 39:257-265.
21. Hjerkinn E.M., Abdelnoor M., Breivik L., Bergengen L., Ellingsen I., Seljeflot I., et al. Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 2006, 13(3):325-333.
22. Rizza S., Tesauro M., Cardillo C., Galli A., Iantorno M., Gigli F., et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 2009, 206(2):569-574.
23. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. Am Coll Cardiol 2000, 35(2):265-270.
24. Schiano V., Laurenzano E., Brevetti G., De Maio J.I., Lanero S., Scopacasa F., et al. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr 2008, 27(2):241-247.
25. Lee K.W., Blann A.D., Lip G.Y. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 2006, 111:302-308.
26. Lee J.H., O'Keefe J.H., Lavie C.J., Marchioli R., Harris W.S. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc 2008, 83(3):324-332.
27. Hassanabad Z.F., Furman B.L., Parratt J.R., Aughey E. Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts. Basic Res Cardiol 1998, 93(4):241-249.
28. Lerman A., Zeiher A.M. Endothelial function: cardiac events. Circulation 2005, 111(3):363-368.
29. Furukawa T., Moroe K., Mayrovitz H.N., Sampsell R., Furukawa N., Myerburg R.J. Arrhythmogenic effects of graded coronary blood flow reductions superimposed on prior myocardial infarction in dogs. Circulation 1991, 84:368-377.
30. El-Maraghi N., Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980, 62:936-944.
31. Calò L., Bianconi L., Colivicchi F., Lamberti F., Loricchio M.L., de Ruvo E., et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005, 45(10):1723-1728.
32. Okuda Y., Kawashima K., Sawada T., Tsurumaru K., Asano M., Suzuki S., et al. Eicosapentanoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997, 232:487-491.
33. Stillwell W., Wassall S.R. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 2003, 126:1-27.
34. Goode G.K., Garcia S., Heagerty A.M. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 1997, 96:2802-2807.
35. Vitale C., Cerquetani E., Wajngarten M., Leonardo F., Silvestri A., Mercuro G., et al. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy. Ital Heart J 2003, 4(9):627-632.
36. Akcakoyun M., Kargin R., Tanalp A.C., Pala S., Ozveren O., Akcay M., et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis 2008, 19(5):337-343.
37. Frøbert O., Hjortshøj S.P., Simonsen U., Ravkilde J. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. Int J Cardiol 2008, 129(2):288-291. 26.
38. Yada T., Kaji S., Kasaka T., Mochizuki S., Ogasawara Y., Tanemoto K., et al. Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clin Hemorheol Microcirc 2007, 37:269-276.
39. Eid H.M., Eritsland J., Larsen J., Arnesen H., Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of Pravastatin.Atherosclerosis 2003, 166:279-284.
40. Paiva H., Laakso J., Lehtimaki T., Isomustajarvi M., Ruokonen I., Laaksonen R. Effect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors. J Cardiovasc Pharmacol 2003, 41:219-222.
41. Schulze F., Maas R., Freese R., Schwedhelm E., Silberhorn E., Böger R.H. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest 2005, 35(10):622-626.
42. Cooke J.P. Does ADMA cause endothelial dysfunction?. Arterioscler Thromb Vasc Biol 2000, 20:2032-2037.
43. Bae S.W., Stühlinger M.C., Yoo H.S., Yu K.H., Park H.K., Choi B.Y., et al. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 2005, 95(6):729-733.
44. Zoccali C., Maas R., Cutrupi S., Pizzini P., Finocchiaro P., Cambareri F., et al. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007, 22(3):801-806.
45. Krempl T.K., Maas R., Sydow K., Meinertz T., Boger R.H., Kahler J. Elevation of asymmetric dimethylarginine in patients. with unstable angina and recurrent cardiovascular. events. Eur Heart J 2005, 26:1846-1851.
46. Kasprzak J.D., Kłosińska M., Drozdz J. Clinical aspects of assessment of endothelial function. Pharmacol Rep 2006, 58:33-40.